|
|
|
|
| Join Cell & Gene Live for an exclusive look at cutting-edge manufacturing technologies revolutionizing cell therapy production. Our expert panel will explore organoids, 3D cultures, automation, and scalable solutions to streamline processes and enhance efficiency. Gain insights into the latest innovations driving the future of cell therapy. Registration is free thanks to the support of CPC and MaxCyte. |
|
|
|
|
A conversation with Nic Preyat, UCB | The potential safety impact of residual hcDNA remains largely unknown, but researchers at UCB are investigating to learn more and mitigate if necessary. | |
|
|
| TFDF-Based Intensified Virus Production | Application Note | Repligen | Learn how Tangential Flow Depth Filtration (TFDF) enhances viral vector production, streamlining the clarification process and increasing efficiency and yield for LV and AAV manufacturing. |
|
|
| Key Factors For Successful Plasmid Production | White Paper | By Stefan Schlößer, Eric Vincent, Ruchika Sharma, Samuel Ellis, and Ines Hartmann, Eppendorf SE | Review the distinct steps in the plasmid production workflow, along with tips for optimization from vector and strain selection to cultivation and beyond. |
|
|
| Ways To Enhance Access To Cell Therapies | e-book | Terumo BCT | Cell therapies are revolutionizing cancer care, but their complex manufacturing and high costs bar access for many patients. Automation is emerging as an efficacious solution to reach patients in need. |
|
|
|
|
|
|
|
| Accelerating CGT Development | Article | By Brad N. Taylor, Ph.D., Nucleus Biologics | The EXCiPACT certification for Excipient GMP quality media and buffers ensures the safety, efficacy, and scalability of cell and gene therapies, accelerating development and improving patient access. |
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
